Does the media prefer ADUS or HIMS?

In the previous week, Hims & Hers Health had 16 more articles in the media than Addus HomeCare. MarketBeat recorded 20 mentions for Hims & Hers Health and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.90 beat Hims & Hers Health's score of 0.58 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 8 Very Positive mention(s) 8 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, ADUS or PACS?

PACS Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Addus HomeCare $1.42B 1.27 $95.91M $5.41 17.90 PACS Group $5.29B 1.25 $191.54M $1.56 26.79

Does the media favor ADUS or PACS?

In the previous week, PACS Group had 11 more articles in the media than Addus HomeCare. MarketBeat recorded 15 mentions for PACS Group and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.90 beat PACS Group's score of 0.39 indicating that Addus HomeCare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Addus HomeCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 4 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, BLLN or ADUS?

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 17.81 $7.45M $0.55 214.85 Addus HomeCare $1.42B 1.27 $95.91M $5.41 17.90

Does the media prefer BLLN or ADUS?

In the previous week, Billiontoone and Billiontoone both had 4 articles in the media. Addus HomeCare's average media sentiment score of 0.90 beat Billiontoone's score of 0.20 indicating that Addus HomeCare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Addus HomeCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor SHC or ADUS?

In the previous week, Addus HomeCare had 2 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for Addus HomeCare and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.87 beat Addus HomeCare's score of 0.90 indicating that Sotera Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sotera Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Addus HomeCare 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Addus HomeCare (ADUS) Competitors

$96.83 -0.03 (-0.03%)

Closing price 03:59 PM Eastern

Extended Trading

$96.94 +0.11 (+0.11%)

As of 07:20 PM Eastern

Compare

ADUS vs. HIMS, PACS, CAI, BLLN, and SHC

Should you buy Addus HomeCare stock or one of its competitors? MarketBeat compares Addus HomeCare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Addus HomeCare include Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), Billiontoone (BLLN), and Sotera Health (SHC). These companies are all part of the "healthcare" industry.

How does Addus HomeCare compare to Hims & Hers Health?

Addus HomeCare (NASDAQ:ADUS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

95.4% of Addus HomeCare shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Addus HomeCare presently has a consensus price target of $131.00, suggesting a potential upside of 35.29%. Hims & Hers Health has a consensus price target of $29.37, suggesting a potential downside of 13.28%. Given Addus HomeCare's stronger consensus rating and higher possible upside, equities analysts plainly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Addus HomeCare has a beta of 0.89, indicating that its stock price is 11% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.37, indicating that its stock price is 137% more volatile than the broader market.

Addus HomeCare has a net margin of 6.89% compared to Hims & Hers Health's net margin of -0.56%. Addus HomeCare's return on equity of 9.80% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
Hims & Hers Health	-0.56%	6.10%	1.52%

In the previous week, Hims & Hers Health had 16 more articles in the media than Addus HomeCare. MarketBeat recorded 20 mentions for Hims & Hers Health and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.90 beat Hims & Hers Health's score of 0.58 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	8 Very Positive mention(s)	8 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has higher revenue and earnings than Addus HomeCare. Hims & Hers Health is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.27	$95.91M	$5.41	17.90
Hims & Hers Health	$2.35B	3.34	$128.37M	-$0.09	N/A

Summary

Addus HomeCare beats Hims & Hers Health on 11 of the 17 factors compared between the two stocks.

How does Addus HomeCare compare to PACS Group?

Addus HomeCare (NASDAQ:ADUS) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, risk, earnings, analyst recommendations and profitability.

95.4% of Addus HomeCare shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by company insiders. Comparatively, 70.1% of PACS Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

PACS Group has higher revenue and earnings than Addus HomeCare. Addus HomeCare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.27	$95.91M	$5.41	17.90
PACS Group	$5.29B	1.25	$191.54M	$1.56	26.79

Addus HomeCare has a net margin of 6.89% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
PACS Group	4.49%	26.47%	4.36%

In the previous week, PACS Group had 11 more articles in the media than Addus HomeCare. MarketBeat recorded 15 mentions for PACS Group and 4 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 0.90 beat PACS Group's score of 0.39 indicating that Addus HomeCare is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Addus HomeCare	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	4 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Addus HomeCare currently has a consensus target price of $131.00, suggesting a potential upside of 35.29%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 14.87%. Given Addus HomeCare's higher possible upside, equities research analysts clearly believe Addus HomeCare is more favorable than PACS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Summary

Addus HomeCare beats PACS Group on 9 of the 16 factors compared between the two stocks.

How does Addus HomeCare compare to Caris Life Sciences?

Addus HomeCare (NASDAQ:ADUS) and Caris Life Sciences (NASDAQ:CAI) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Addus HomeCare has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Addus HomeCare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Addus HomeCare	$1.42B	1.27	$95.91M	$5.41	17.90
Caris Life Sciences	$812.03M	6.44	-$68.09M	-$7.61	N/A

Addus HomeCare currently has a consensus price target of $131.00, suggesting a potential upside of 35.29%. Caris Life Sciences has a consensus price target of $27.56, suggesting a potential upside of 48.95%. Given Caris Life Sciences' higher probable upside, analysts clearly believe Caris Life Sciences is more favorable than Addus HomeCare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45

95.4% of Addus HomeCare shares are owned by institutional investors. 4.1% of Addus HomeCare shares are owned by insiders. Comparatively, 50.0% of Caris Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Addus HomeCare has a net margin of 6.89% compared to Caris Life Sciences' net margin of 3.75%. Caris Life Sciences' return on equity of 98.28% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Addus HomeCare	6.89%	9.80%	7.34%
Caris Life Sciences	3.75%	98.28%	48.87%

In the previous week, Addus HomeCare had 3 more articles in the media than Caris Life Sciences. MarketBeat recorded 4 mentions for Addus HomeCare and 1 mentions for Caris Life Sciences. Caris Life Sciences' average media sentiment score of 1.42 beat Addus HomeCare's score of 0.90 indicating that Caris Life Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Addus HomeCare	Positive
Caris Life Sciences	Positive

Summary

Addus HomeCare beats Caris Life Sciences on 8 of the 14 factors compared between the two stocks.

How does Addus HomeCare compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Addus HomeCare (NASDAQ:ADUS) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

95.4% of Addus HomeCare shares are held by institutional investors. 4.1% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Addus HomeCare has a net margin of 6.89% compared to Billiontoone's net margin of 0.00%. Addus HomeCare's return on equity of 9.80% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	N/A	N/A	N/A
Addus HomeCare	6.89%	9.80%	7.34%

In the previous week, Billiontoone and Billiontoone both had 4 articles in the media. Addus HomeCare's average media sentiment score of 0.90 beat Billiontoone's score of 0.20 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Addus HomeCare	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone currently has a consensus target price of $125.29, suggesting a potential upside of 6.02%. Addus HomeCare has a consensus target price of $131.00, suggesting a potential upside of 35.29%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts plainly believe Addus HomeCare is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70

Addus HomeCare has higher revenue and earnings than Billiontoone. Addus HomeCare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	17.81	$7.45M	$0.55	214.85
Addus HomeCare	$1.42B	1.27	$95.91M	$5.41	17.90

Summary

Addus HomeCare beats Billiontoone on 12 of the 13 factors compared between the two stocks.

How does Addus HomeCare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, media sentiment, earnings, dividends, profitability, valuation and risk.

In the previous week, Addus HomeCare had 2 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for Addus HomeCare and 2 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.87 beat Addus HomeCare's score of 0.90 indicating that Sotera Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sotera Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Addus HomeCare	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 95.4% of Addus HomeCare shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 4.1% of Addus HomeCare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Sotera Health has a beta of 1.79, indicating that its share price is 79% more volatile than the broader market. Comparatively, Addus HomeCare has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market.

Sotera Health currently has a consensus price target of $20.25, indicating a potential upside of 16.51%. Addus HomeCare has a consensus price target of $131.00, indicating a potential upside of 35.29%. Given Addus HomeCare's higher possible upside, analysts plainly believe Addus HomeCare is more favorable than Sotera Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Addus HomeCare	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.70

Addus HomeCare has higher revenue and earnings than Sotera Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.26	$77.94M	$0.41	42.39
Addus HomeCare	$1.42B	1.27	$95.91M	$5.41	17.90

Sotera Health has a net margin of 9.91% compared to Addus HomeCare's net margin of 6.89%. Sotera Health's return on equity of 39.73% beat Addus HomeCare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Addus HomeCare	6.89%	9.80%	7.34%

Summary

Sotera Health beats Addus HomeCare on 9 of the 17 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADUS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ADUS vs. The Competition

Export

Metric	Addus HomeCare	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.81B	$5.92B	$6.71B	$12.24B
Dividend Yield	N/A	1.50%	2.67%	6.09%
P/E Ratio	17.90	35.89	22.04	22.24
Price / Sales	1.27	29.51	556.74	101.67
Price / Cash	14.91	17.83	46.99	54.37
Price / Book	1.65	3.52	10.77	6.35
Net Income	$95.91M	$218.81M	$3.57B	$337.63M
7 Day Performance	2.76%	7.01%	3.15%	-0.30%
1 Month Performance	3.92%	8.13%	2.33%	0.36%
1 Year Performance	-16.27%	24.71%	33.42%	26.94%

Addus HomeCare Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ADUS Addus HomeCare	4.1495 of 5 stars	$96.83 0.0%	$131.00 +35.3%	-14.6%	$1.81B	$1.42B	17.90	50,659	High Trading Volume
HIMS Hims & Hers Health	2.4821 of 5 stars	$30.74 +1.9%	$28.70 -6.6%	-20.8%	$7.11B	$2.35B	N/A	2,442	Trending News Insider Trade Gap Down
PACS PACS Group	3.0263 of 5 stars	$36.27 +0.1%	$48.00 +32.3%	+215.3%	$5.75B	$5.29B	23.30	47,455	News Coverage Analyst Forecast Insider Trade
CAI Caris Life Sciences	4.1871 of 5 stars	$18.24 +0.3%	$27.56 +51.1%	N/A	$5.16B	$812.03M	N/A	1,846	Positive News
BLLN Billiontoone	2.7488 of 5 stars	$100.05 -3.7%	$125.29 +25.2%	N/A	$4.66B	$305.11M	184.24	620	Analyst Upgrade Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ADUS) was last updated on 6/26/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Addus HomeCare (ADUS) Competitors

ADUS vs. HIMS, PACS, CAI, BLLN, and SHC

How does Addus HomeCare compare to Hims & Hers Health?

Summary

How does Addus HomeCare compare to PACS Group?

Summary

How does Addus HomeCare compare to Caris Life Sciences?

Summary

How does Addus HomeCare compare to Billiontoone?

Summary

How does Addus HomeCare compare to Sotera Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Addus HomeCare (ADUS) Competitors

ADUS vs. HIMS, PACS, CAI, BLLN, and SHC

How does Addus HomeCare compare to Hims & Hers Health?

Do insiders & institutionals believe in ADUS or HIMS?

Do analysts prefer ADUS or HIMS?

Which has more volatility and risk, ADUS or HIMS?

Is ADUS or HIMS more profitable?

Does the media prefer ADUS or HIMS?

Which has preferable earnings & valuation, ADUS or HIMS?

Summary

How does Addus HomeCare compare to PACS Group?

Do institutionals and insiders believe in ADUS or PACS?

Which has stronger valuation & earnings, ADUS or PACS?

Is ADUS or PACS more profitable?

Does the media favor ADUS or PACS?

Do analysts rate ADUS or PACS?

Summary

How does Addus HomeCare compare to Caris Life Sciences?

Which has stronger earnings & valuation, ADUS or CAI?

Do analysts recommend ADUS or CAI?

Do institutionals & insiders hold more shares of ADUS or CAI?

Is ADUS or CAI more profitable?

Does the media favor ADUS or CAI?

Summary

How does Addus HomeCare compare to Billiontoone?

Do insiders & institutionals believe in BLLN or ADUS?

Is BLLN or ADUS more profitable?

Does the media prefer BLLN or ADUS?

Do analysts rate BLLN or ADUS?

Which has higher valuation and earnings, BLLN or ADUS?

Summary

How does Addus HomeCare compare to Sotera Health?

Does the media favor SHC or ADUS?

Do insiders and institutionals believe in SHC or ADUS?

Which has more risk and volatility, SHC or ADUS?

Do analysts prefer SHC or ADUS?

Which has stronger valuation and earnings, SHC or ADUS?

Is SHC or ADUS more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ADUS vs. The Competition

Addus HomeCare Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools